Abstract

Extensive use of herbicides is common among agriculture workers in Sri Lanka (SL). Recent studies hypothesized the role of agrochemicals in the development of mysterious chronic kidney disease termed as CKDu. Paraquat and Glyphosate were leading herbicides among sugarcane farmers (SF) hence occupational exposure is inevitable. This study reports detection of urinary Paraquat and Glyphosate residues among SF residing in CKDu emerging regions (Uva province; Warunagama and Rahathangama) of SL along with tubular injury biomarkers KIM I and NGAL. Collected urine samples were compared with non-endemic controls (CN) (Southern province; Matara). Paraquat, Glyphosate, KIM I and NGAL levels (Warunagama, n = 66; Rahathangama, n = 69; Matara, n = 66) were estimated using Enzyme Linked Immunosorbent Assays. Urinary creatinine, microalbumin and albumin creatinine ratio (ACR) were also assessed for kidney function. Generally herbicide residues and injury biomarkers were higher in SF with compared to CN. Creatinine adjusted urinary glyphosate and paraquat levels were significantly higher in Warunagama (271.3 ± 23.7 µg/g Cr, 2.08 ± 0.33 µg/g Cr; p < 0.001) but not in Rahathangama (250.4 ± 18.8 µg/g Cr, 0.79 ± 0.12 µg/g Cr; p > 0.05) when compared with CN (191.2 ± 14.2 µg/g Cr, 0.67 ± 0.05 µg/g Cr). Urinary NGAL levels were significantly higher (12.4 ± 4.7 ng/mg Cr p < 0.0001, 12.0 ± 2.8 ng/mg Cr; p < 0.0001) in both Warunagama and Rahathangama. However, urinary KIM I levels were not significant (101.6 ± 25.0 ng/g Cr, 114.6 ± 25.5 ng/g Cr; P>0.05) with compared to CN (34.9 ± 20.1 ng/g Cr, 1.8 ± 0.4 ng/g Cr). In conclusion, current study confirms higher urinary herbicides levels in SF, potentially due to occupational exposure. Similarly, higher urinary KIM I and NGAL levels were also reported in both CKDu emerging locations and could be link with elevated herbicide residue levels. However, low but detectable levels of urinary herbicide, KIM I and NGAL in non-endemic controls may support dietary exposure and warrants further studies.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.